Assignee
ATRECA INC
US·7 granted patents·16 pending applications·31 citations·filing 2014–2023
Top patents by PatentIndex Score
23 records- 0190US9580736B2Analysis of nucleic acids associated with single cells using nucleic acid barcodesATRECA INC·Filed 2014·Granted Feb 28, 2017·22 cites·24 claims
- 0289US10316345B2Analysis of nucleic acids associated with single cells using nucleic acid barcodesATRECA INC·Filed 2017·Granted Jun 11, 2019·6 cites·25 claims
- 0386US11472885B2Antibodies that bind tumor tissue for diagnosis and therapyATRECA INC·Filed 2020·Granted Oct 18, 2022·3 cites·36 claims
- 0477US2022389471A1Analysis of nucleic acids associated with single cells using nucleic acid barcodesATRECA INC·Filed 2022·Application pending·0 cites
- 0577US2022389472A1Analysis of nucleic acids associated with single cells using nucleic acid barcodesATRECA INC·Filed 2022·Application pending·0 cites
- 0677US2022243240A1Analysis of nucleic acids associated with single cells using nucleic acid barcodeATRECA INC·Filed 2022·Application pending·0 cites
- 0771US2020123582A1Analysis of nucleic acids associated with single cells using nucleic acid barcodesATRECA INC·Filed 2019·Application pending·0 cites
- 0871US2022155319A1Use of nanoexpression to interrogate antibody repertoiresATRECA INC·Filed 2022·Application pending·0 cites
- 0966US12545723B2Anti-CSP antibodiesATRECA INC·Filed 2023·Granted Feb 10, 2026·0 cites·33 claims
- 1063US11655290B2Anti-CSP antibodiesATRECA INC·Filed 2022·Granted May 23, 2023·0 cites·31 claims
- 1162US10620219B2Use of nanoexpression to interrogate antibody repertoiresATRECA INC·Filed 2017·Granted Apr 14, 2020·0 cites·7 claims
- 1262US2023140035A1Antibodies that bind tumor tissue for diagnosis and therapyATRECA INC·Filed 2022·Application pending·0 cites
- 1360US2021380974A1Combinatorial sets of nucleic acid barcodes for analysis of nucleic acids associated with single cellsATRECA INC·Filed 2021·Application pending·0 cites
- 1459US2015011405A1Use of Nanoexpression to Interrogate Antigen RepertoiresATRECA INC·Filed 2014·Application pending·0 cites
- 1557US2023381130A1Antibody scaffold structureATRECA INC·Filed 2023·Application pending·0 cites
- 1657US2020355698A1Use of nanoexpression to interrogate antibody repertoiresATRECA INC·Filed 2020·Application pending·0 cites
- 1754US2023220376A1High throughput linking of multiple transcriptsATRECA INC·Filed 2021·Application pending·0 cites
- 1851US11098304B2Combinatorial sets of nucleic acid barcodes for analysis of nucleic acids associated with single cellsATRECA INC·Filed 2016·Granted Aug 24, 2021·0 cites·40 claims
- 1951US2024301038A1Antibodies to sars-cov-2ATRECA INC·Filed 2022·Application pending·0 cites
- 2048US2021040185A1Anti-hiv antibodiesATRECA INC·Filed 2020·Application pending·0 cites
- 2147US2021040184A1Anti-hiv antibodiesATRECA INC·Filed 2020·Application pending·0 cites
- 2246US2024025971A1Antibodies to coronavirus sars-cov-2ATRECA INC·Filed 2021·Application pending·0 cites
- 2346US2022195023A1Anti-csp antibody variantsATRECA INC·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when ATRECA INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →